Literature DB >> 19848249

Glucocorticoid receptor immunoreactivity of eosinophils in nasal polyps.

Mei Yu1, So Watanabe, Mutsuo Kudo, Ken-Ichi Kanai, Harumi Suzaki.   

Abstract

CONCLUSION: The higher level of glucocorticoid receptor (GR) expression in cases of chronic sinusitis with bronchial asthma or allergic rhinitis suggests that glucocorticoids may exert a greater influence on eosinophils, thereby making them more effective in the treatment of polyps or chronic sinusitis.
OBJECTIVES: The GR immunoreactivity of eosinophils in nasal polyps was investigated to elucidate the mechanism by which glucocorticoids interact with eosinophils.
MATERIALS AND METHODS: Nasal polyp specimens were divided into 3 groups: 7 patients with chronic sinusitis alone (CS only group), 12 patients with chronic sinusitis complicated by perennial allergic rhinitis (CS/AR group), and 6 patients with chronic sinusitis complicated by bronchial asthma except for aspirin-induced asthma (CS/asthma group). Immunofluorescent staining with an anti-GR polyclonal antibody and anti-major basic protein (MBP) monoclonal antibody was used.
RESULTS: The total number of MBP+ cells, GR+ cells, and MBP+/GR+ cells in the CS/asthma group was significantly higher than that in the other two groups. The total number of these cells in the CS/AR group was also higher than that in the CS only group The ratio of MBP+/GR+ cells to GR+ cells was highest in the CS/asthma group. The ratio of MBP+/GR+ cells to MBP+ cells in the CS only group was lower than those in the other two groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19848249     DOI: 10.1080/00016480902915723

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  1 in total

1.  Expression of the cysteinyl leukotriene 1 receptor and glucocorticoid receptor-β in nasal polyps.

Authors:  Yong-Hwi An; Sung-Lyong Hong; Doo Hee Han; Chul Hee Lee; Yang-Gi Min; Chae-Seo Rhee
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-03       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.